Techniques For Quality Assurance Testing Template

In plain language: Identifies the contracting parties, the specific product or system subject to QA testing, and the version or release to which the agreement applies.

Common mistake: Referencing a project name instead of a specific deliverable version — leaving it ambiguous whether the QA obligations carry over to future releases.

In plain language: Specifies which testing types will be performed — unit, integration, system, regression, performance, and UAT — and which party is responsible for executing each.

Common mistake: Listing testing types without assigning responsibility. When a defect emerges, both parties point at each other if accountability is not explicit.

In plain language: Defines what measurable conditions the deliverable must meet to be accepted — including the percentage of test cases that must pass and maximum allowable open defects by severity.

Common mistake: Defining acceptance as 'all tests passing' without a defect severity carve-out — a single cosmetic issue can block delivery and trigger dispute.

In plain language: Establishes a severity taxonomy (critical, major, minor, cosmetic), requires defects to be logged in a specified tool, and defines the format and timing of defect reports.

Common mistake: Not defining a defect severity matrix. Vendors and clients routinely disagree on whether a defect is 'critical' or 'major' when money depends on the classification.

In plain language: States how quickly each severity class of defect must be resolved, tested, and re-submitted for client review after identification.

Common mistake: Setting identical remediation timelines for all defect severities. Critical production blockers require faster turnaround than cosmetic issues, and conflating them removes any urgency.

In plain language: Defines what the client must provide — test data, environment access, timely feedback, and UAT resources — and the consequences of client delay on remediation timelines.

Common mistake: Omitting client obligations entirely. When UAT stalls due to the client's failure to provide test data, the vendor has no contractual basis to extend their delivery timeline.

In plain language: Establishes the process by which the client formally accepts the deliverable in writing, the effect of deemed acceptance after a period of no response, and the limitations of acceptance.

Common mistake: No deemed-acceptance provision. Without it, a client who delays sign-off indefinitely can hold the vendor in a perpetual state of non-delivery.

In plain language: Allocates financial responsibility for defects that survive acceptance — including warranty periods, liability caps, and exclusions for defects caused by client modifications.

Common mistake: No liability cap. Without one, a single post-acceptance defect in a mission-critical system can expose the vendor to losses far exceeding the contract value.

In plain language: Requires any change to test scope, acceptance criteria, or deliverable requirements to go through a formal written change order signed by both parties.

Common mistake: Allowing verbal scope changes during UAT. Undocumented changes to requirements invalidate the original acceptance criteria and make dispute resolution nearly impossible.

In plain language: Specifies the jurisdiction whose law governs the agreement and how disputes — particularly defect disagreements — are resolved, whether by arbitration, expert determination, or litigation.

Common mistake: Standard arbitration clauses without a technical expert determination carve-out for QA disputes. Arbitrators rarely have the technical expertise to evaluate software defect severity — an expert determination clause resolves these disputes faster and cheaper.

A quality assurance testing agreement is a binding contract that defines the testing methodologies, acceptance criteria, defect classification standards, remediation timelines, and liability allocation that govern the delivery of a product or software system. It replaces informal expectations with measurable, enforceable obligations on both the vendor delivering the product and the client accepting it.

Any time a vendor or internal team is delivering software, a manufactured product, or a system where defects carry financial, operational, or regulatory consequences. It is particularly important for custom software development, outsourced testing engagements, regulated industry products (medical devices, financial systems), and any project where final payment is tied to formal acceptance.

A software development agreement governs the full development engagement — scope, IP ownership, fees, timelines, and delivery. A QA testing agreement is either a standalone document governing a dedicated testing engagement or an exhibit to the development agreement that specifically defines how quality will be measured and enforced. The two documents work together; the QA agreement provides the technical and legal precision that generic development contracts lack.

A comprehensive QA agreement typically covers unit testing, integration testing, system testing, regression testing, performance testing, and user acceptance testing (UAT). Each should be assigned to a responsible party with defined tools, frequency, and output artifacts. The specific mix depends on the product type — software products generally require all six; manufactured products substitute functional and durability testing for unit and regression testing.

Acceptance criteria are enforceable when they are specific, measurable, and agreed in writing before testing begins. Vague standards like 'the system shall perform well' are unenforceable. Enforceable criteria state a specific pass rate (e.g., 95% of test cases), a maximum defect count by severity class, and a defined test environment. Attaching a signed test plan as a schedule strengthens enforceability significantly.

Define four levels — critical, major, minor, and cosmetic — with product-specific examples for each. Critical defects prevent core functionality from operating for any user. Major defects impair significant functionality with no workaround. Minor defects have a workaround available. Cosmetic defects affect appearance only with no functional impact. Link each severity level to a specific remediation timeline in the body of the contract.

In several industries, a documented QA process is a regulatory requirement rather than a best practice. FDA software validation under 21 CFR Part 11 and Part 820 requires documented testing protocols and acceptance criteria. ISO 9001 mandates documented quality management procedures. HIPAA-covered entities must validate software handling protected health information. In these contexts, the QA agreement forms part of the audit trail regulators will request.

The agreement should define consequences for non-conforming delivery: the vendor is typically required to remediate within the defect-class timeline at no additional cost, re-submit for testing, and repeat until acceptance criteria are met. If critical defects persist beyond the remediation period, the client may have the right to withhold payment, engage a substitute vendor to remediate at the original vendor's cost, or terminate the contract for cause.

Yes. A QA testing agreement and all attached schedules — including the defect severity matrix and acceptance criteria — should be signed by authorized representatives of both parties before testing begins. Electronic signatures are generally valid in the US, Canada, the UK, and the EU under applicable e-signature legislation, provided the platform creates a tamper-evident audit trail.